10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001638833-22-000122`
Period End Date	20220630
Filing Date	20220802
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	sgry-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 121 Cash Flow Statement 84 Stockholders Equity 41 Comprehensive Income 22

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$272.30M	USD	Point-in-time
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$320.70M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$389.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$227.40M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$412.00M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$430.20M	USD	Point-in-time
Inventories	`InventoryNet`	$61.10M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$64.00M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$25.60M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$37.40M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$47.60M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$39.30M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$946.10M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	89.94M	shares	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	89.33M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$788.40M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$789.10M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	89.94M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$629.70M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.04B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.96B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$88.70M	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$159.70M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$277.80M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$324.10M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$114.40M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$110.40M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$130.60M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$59.10M	USD	Point-in-time
Total assets	`Assets`	$6.12B	USD	Point-in-time
Total assets	`Assets`	$6.29B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$126.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$124.90M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$77.10M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$83.80M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$21.40M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$64.40M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$221.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$210.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$68.30M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$60.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$536.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$521.70M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$3.02B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.88B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$315.60M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$271.80M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$96.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$87.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$330.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$312.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$341.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$306.80M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,935,287 and 89,332,557, respectively	`CommonStockValueOutstanding`	$900.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,935,287 and 89,332,557, respectively	`CommonStockValueOutstanding`	$900.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.62B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.62B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-31.50M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$44.30M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-508.90M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-502.70M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$1.09B	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$1.16B	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$880.60M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$885.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.29B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.12B	USD	Point-in-time

Income Statement 121 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$615.40M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$543.30M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.06B	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.21B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$360.80M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$307.00M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$181.90M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$155.30M	USD	1 Quarter
Supplies	`SuppliesExpense`	$345.10M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$157.50M	USD	1 Quarter
Supplies	`SuppliesExpense`	$173.50M	USD	1 Quarter
Supplies	`SuppliesExpense`	$304.80M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$57.40M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$66.70M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$112.90M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$130.30M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$40.20M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$22.60M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$45.40M	USD	2 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$20.20M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$75.80M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$32.20M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$63.80M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$38.50M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$952.20M	USD	2 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$480.80M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$425.00M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$833.90M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$55.60M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$51.30M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$24.50M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$26.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$50.90M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$55.40M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$28.00M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$15.30M	USD	2 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$8.20M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$14.50M	USD	2 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$9.20M	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.30M	USD	2 Qtrs
Grant funds	`GrantRevenue`	$100.00K	USD	1 Quarter
Grant funds	`GrantRevenue`	$4.90M	USD	1 Quarter
Grant funds	`GrantRevenue`	$20.00M	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-100.00K	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.10M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$3.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$5.60M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$5.70M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$2.60M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	Point-in-time
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.60M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.80M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.80M	USD	2 Qtrs
Other income, net	`OtherNonrecurringIncomeExpense`	$-5.00M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$931.90M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$483.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.03B	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$538.90M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$176.90M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$123.80M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$59.50M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$76.50M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-106.70M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-56.90M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-53.40M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-113.20M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$63.70M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$17.10M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$19.60M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$6.10M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-2.70M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$4.30M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-2.50M	USD	2 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$5.60M	USD	2 Qtrs
Net income	`ProfitLoss`	$19.60M	USD	2 Qtrs
Net income	`ProfitLoss`	$58.10M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.80M	USD	1 Quarter
Net income	`ProfitLoss`	$15.30M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$33.70M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$67.50M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$64.30M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$35.70M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-18.40M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-47.90M	USD	2 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-26.90M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-6.20M	USD	2 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	-	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.30M	USD	2 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	-	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	-	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.90M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.20M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-58.20M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.40M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.07	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.21	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.94	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.39	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.94	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.21	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.39	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.07	USD	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	69.27M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	62.06M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.90M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.45M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	69.27M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.45M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	62.06M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.90M	shares	1 Quarter

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$19.60M	USD	2 Qtrs
Net income	`ProfitLoss`	$58.10M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.80M	USD	1 Quarter
Net income	`ProfitLoss`	$15.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$50.90M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$55.40M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$28.00M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-5.70M	USD	2 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-12.40M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$8.00M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.10M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$9.30M	USD	2 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.30M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-100.00K	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.10M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	2 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.00M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.60M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.90M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.20M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$400.00K	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$400.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$17.10M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$20.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.40M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.10M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-40.20M	USD	2 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-28.80M	USD	2 Qtrs
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	$32.20M	USD	2 Qtrs
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	-	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-5.00M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-200.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$121.90M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$52.50M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$40.60M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.00M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$15.20M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$74.90M	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	-	USD	2 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$2.50M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$65.80M	USD	2 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	-	USD	2 Qtrs
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$11.50M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$11.60M	USD	2 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-40.70M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-181.40M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$309.40M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$33.30M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$283.10M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$12.40M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$8.70M	USD	2 Qtrs
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	$2.40M	USD	2 Qtrs
Payment of premium on debt extinguishment	`DebtInstrumentPrepaymentPenaltyAmount`	-	USD	2 Qtrs
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	$260.90M	USD	2 Qtrs
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	$12.70M	USD	2 Qtrs
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$5.10M	USD	2 Qtrs
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$63.40M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$75.20M	USD	2 Qtrs
(Payments) receipts related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$4.00M	USD	2 Qtrs
(Payments) receipts related to ownership transactions with non-controlling interest holders	`ProceedsFromMinorityShareholders`	$3.40M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.90M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.90M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$134.80M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-103.00M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$146.60M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-162.50M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$227.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$464.80M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$227.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$464.80M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	89.94M	shares	Point-in-time
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$4.30M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$32.20M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-4.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$100.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.40M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.70M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.30M	USD	1 Quarter
Equity offering	`StockIssuedDuringPeriodValueNewIssues`	$248.30M	USD	1 Quarter
Preferred share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$439.70M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$19.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$200.00K	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$75.80M	USD	2 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$56.80M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.60M	USD	2 Qtrs
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$27.90M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$5.60M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-29.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$2.30M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$27.70M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$24.60M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$22.30M	USD	1 Quarter
Balance at end of period (shares)	`CommonStockSharesOutstanding`	89.94M	shares	Point-in-time
Balance at end of period (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time

Comprehensive Income 22 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$19.60M	USD	2 Qtrs
Net income	`ProfitLoss`	$58.10M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.80M	USD	1 Quarter
Net income	`ProfitLoss`	$15.30M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$19.00M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$200.00K	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$75.80M	USD	2 Qtrs
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$56.80M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.60M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$9.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$133.90M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$26.20M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$34.30M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$35.70M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$64.30M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$67.50M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$33.70M	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$600.00K	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-26.70M	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$69.60M	USD	2 Qtrs
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-41.30M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.